Answers are grounded in this paper and cite their sources.
Objectives This study aims to develop a multimodal model that integrates deep learning radiomics and clinical characteristics to predict the risk of esophageal fistula (EF) after chemotherapy and/or radiotherapy in patients. Methods In this multicentre retrospective study, 186 patients with esophageal squamous cell carcinoma (ESCC) from three institutions were allocated into training (n = 80), internal validation (n = 35), and external validation (n = 71) cohorts. Clinical data were extracted from electronic medical records, and radiomic features were extracted from pretreatment contrast-enhanced CT images. Deep transfer learning features were extracted using residual network-50 (ResNet-50) and combined with radiomic features to construct deep transfer learning radiomics (DTLR) features. Single-modality models based on clinical characteristics, radiomic features, and DTLR features were developed, respectively. A multimodal fusion model was then constructed using decision-level fusion. Model performance was evaluated in terms of discrimination, calibration, and clinical utility, using metrics including the area under the receiver operating characteristic curve (AUC), accuracy (ACC), and sensitivity. Results The multimodal combined model achieved AUCs of 0.957 (95% confidence interval [CI]: 0.917–0.996), 0.922 (95% CI: 0.837–1.000), and 0.865 (95% CI: 0.783–0.948) in the training, internal validation and external validation cohorts, respectively. The combined model achieved higher AUC values than the clinical, radiomics, and DTLR models across all cohorts, although the incremental benefit over the DTLR model was not statistically significant in any cohort. Decision curve analysis demonstrated that the multimodal model provided greater clinical net benefit than each single-modality model. Conclusion The multimodal model integrating clinical, radiomics and DTLR features showed favorable performance for predicting EF after chemotherapy and/or radiotherapy in patients with ESCC. This model may facilitate the identification of high-risk patients and provide guidance for optimizing individualized treatment strategies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: